Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ICAgen obtains patent and exclusive rights to ion channel technology

Feb. 11, 1999

Dexemel drug delivery vehicle approved in the U.K.

Feb. 10, 1999

Nexell awarded U.S. patent for neutropenia therapy

Feb. 10, 1999

Novel gene delivery system available for licensing from NIH

Feb. 9, 1999

Avigen granted U.S. patent for TVI gene therapy

Feb. 9, 1999

Sch-217048: potent and selective neurokinin antagonist from natural sources

Feb. 8, 1999

Genelabs Technologies' DARPA drug discovery grant renewed

Feb. 8, 1999

AxyS and Protein Design Labs enter drug discovery agreement

Feb. 2, 1999

BioFocus and Pharmacia & Upjohn join forces in drug discovery

Feb. 1, 1999

Abgenix and Genentech form new antibody collaboration

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...